COVID-19 as good as cured, page-69

BIT yet to find a compound that works in the lab against COVID19 , by the time they go through preclinical , animal trials , tox ,drug manufacture , human trials , raising cash , etc , the world will be facing the next crisis. They are too late imo .

Just see how long its taken them to even come up with a Hep B compound.

As for BIT225 the small phase2 patient trial numbers and limited patent life is what's stopping any large or small pharma partnering. The lack of any institutional investors , top 20 limited ownership and no Subholders backs this up.